For the past five years, the Center for Bioanalytic Metrology (CBM) at the University of Notre Dame has served as the world’s leading consortium for academic research in analytical science and engineering.
Now, with five years of funding from the National Science Foundation (NSF), the CBM will enter Phase II of its mission to create new capabilities in measurement science and solve current, emerging, and industry-relevant problems, creating value for its corporate, non-profit, and federal members.
CBM director Paul W. Bohn said, “Support from the NSF has allowed the Center for Bioanalytic Metrology at Notre Dame to play a pivotal role in advancing research and product development across a broad spectrum of industries; pharmaceuticals, biotechnology, energy, consumer products, and ag/nutrition sectors are all represented in CBM. We are grateful to the NSF for supporting and affirming these efforts."
Bohn, the Arthur J. Schmitt Professor of Chemical & Biomolecular Engineering and professor of Chemistry & Biochemistry, added, “The CBM's Phase II will lead to enhanced measurement science and more precise instrumentation to ensure that industrial products are safe, accurate, and personalized.”
In addition to serving as the director of the CBM, Bohn is the inaugural director of Notre Dame’s Bioengineering and Life Sciences Initiative, which was launched in the spring of 2024.
For Phase II, Bohn will remain CBM director but step down from his role as Notre Dame site director for the CBM, and Merlin Bruening, the Donald & Susan Rice Professor of Engineering, has accepted the position of site director.
Bruening said, “I look forward to working with Professor Bohn and our colleagues at Purdue University and Indiana University on this important research collaboration with our industry partners.”
The CBM was launched in 2019 as an NSF Phase I Industry-University Cooperative Research Center (IUCRC). The IUCRC program accelerates the impact of basic research through close relationships between industry innovators, world-class academic teams, and government leaders. IUCRCs are designed to help corporate partners and government agencies connect directly and efficiently with university researchers to achieve three primary objectives:
-
Conduct high-impact research to meet shared industrial needs in companies of all sizes;
-
Enhance U.S. global leadership in driving innovative technology development, and;
-
Identify, mentor, and develop a diverse high-tech, exceptionally skilled workforce.
Notre Dame serves as the lead institution with Purdue University and Indiana University Bloomington as partners. During Phase I, the CBM facilitated over three million dollars in industry-relevant measurement science research on behalf of its dues-paying corporate members, including AbbVie, Agilent, Corteva, Evonik, ExxonMobil, Genentech, Bristol Myers Squibb, Lilly, Merck, Moderna, P&G, Pfizer, and Takeda.
Since its inception, the CBM has been at the forefront of developing cutting-edge bioanalytical tools and methodologies. The center's interdisciplinary approach, combining expertise in chemistry, biology, and engineering, has led to significant advancements in understanding complex chemical systems and developing innovative solutions for real-world challenges.
The NSF's renewed support will enable the CBM to expand its research initiatives, foster new collaborations, and accelerate the translation of scientific discoveries into practical applications.
For more information about the Center for Bioanalytic Metrology and its research initiatives, please visit cbm.nd.edu.
Contact: Brett Beasley / Writer and Editorial Program Manager
Notre Dame Research / University of Notre Dame
bbeasle1@nd.edu / +1 574-631-8183
research.nd.edu / @UNDResearch
About Notre Dame Research:
The University of Notre Dame is a private research and teaching university inspired by its Catholic mission. Located in South Bend, Indiana, its researchers are advancing human understanding through research, scholarship, education, and creative endeavor in order to be a repository for knowledge and a powerful means for doing good in the world. For more information, please see research.nd.edu or @UNDResearch.
About the Center for Bioanalytic Metrology:
The Center for Bioanalytic Metrology (CBM) is a partnership between Indiana University, Purdue University, and the University of Notre Dame, who together comprise the world’s leading consortium for academic research in analytical science and engineering. With support from the National Science Foundation, CBM creates value for its corporate, non-profit, and federal members by solving current, emerging, and industry-relevant problems and creating new capabilities in measurement science.
Originally published by at research.nd.edu on August 27, 2024.